NASDAQ · Medical - Diagnostics & Research

Aspira Women's Health Inc. (AWH) Stock

$0.08 -15.90% NASDAQ: AWH Healthcare

Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses.

Valuation

MetricValue
Price$0.08
Market Cap$2.46M
P/E Ratio-0.32
P/B Ratio-0.57
P/S Ratio0.28
EPS (TTM)$-0.37
52-Week High$3.63
52-Week Low$0.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE203.31%
ROA-201.47%
ROCE-400.00%
Gross Margin60.94%
Operating Margin-77.22%
Net Margin-115.13%
Debt/Equity-0.38
Current Ratio0.68

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.0M$8.0M$9.0M$9.0M$9.0M
Operating Profit$-33.0M$-31.0M$-19.0M$-16.0M$-8.0M
Net Profit$-32.0M$-30.0M$-17.0M$-13.0M$-13.0M
EPS$-4.28$-3.85$-1.81$-0.93$-0.37
Op Margin-478.5%-380.5%-205.9%-177.3%-85.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$41.0M$17.0M$6.0M$5.0M$5.0M
Total Liabilities$11.0M$10.0M$9.0M$8.0M$12.0M
Cash$37.0M$13.0M$3.0M$2.0M$2.0M
Borrowings$4.0M$4.0M$3.0M$3.0M$2.0M

Latest News

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now? Zacks · Jul 17, 2026 Zacks Initiates Coverage of Aspira With Neutral Recommendation Zacks · Jun 16, 2026 Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health ACCESS Newswire · May 26, 2026 Aspira: Q1 Earnings Snapshot Associated Press · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-27.0M$-31.0M$-16.0M$-12.0M$-7.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$-1.0M$0$1.0M$7.0M
Net Cash Flow$21.0M$-24.0M$-11.0M$-1.0M$0
Free Cash Flow$-28.0M$-31.0M$-16.0M$-12.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA1.77
FCF Yield-174.98%
Quick Ratio0.62
Interest Coverage33.38
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AFMDAffimed N.V. $0.18 +0.00% -0.02 $2.98M 0.00%
APDNApplied DNA Sciences, Inc. $5.62 +31.62% -0.05 $7.26M 0.00%
ARAVAravive, Inc. $0.04 -13.39% -0.02 $2.95M 0.00%
BPTSBiophytis S.A. $8.22 -13.47% -0.57 $2.61M 0.00%
DMTKQDermTech, Inc. $0.00 — 0.00 $3496 0.00%

About Aspira Women's Health Inc.

Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses. Additionally, they provide ASPiRA GenetiX, a genetic screening option for assessing individual susceptibility to gynecologic cancers. The company operates Aspira Synergy, a cloud-based platform enabling decentralized access to protein biomarker and hereditary genetic testing. Furthermore, Aspira owns and manages ASPiRA LABS, a specialized laboratory dedicated to applying advanced biomarker technologies for the management of gynecologic cancers and related conditions. Its innovation pipeline features upcoming products like OVAWatch, EndoCheck, and OVAInherit. Aspira serves a diverse clientele, including individual physicians, physician office laboratories, and both national and regional laboratory networks. The company actively collaborates with several institutions, holding a research agreement with Baylor Genetics and another with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to explore microRNA technology for enhanced early ovarian cancer detection. A strategic alliance is also in place with Quest Diagnostics, Incorporated. Incorporated in 1993 and headquartered in Austin, Texas, the company adopted its current name, Aspira Women's Health Inc., in June 2020, having previously operated as Vermillion, Inc.

Aspira Women's Health Inc. is headquartered in US.

Aspira Women's Health Inc. (AWH) stock trades at $0.08 with a market capitalization of $2.46M. The stock is valued at a price-to-earnings (P/E) ratio of -0.32, price-to-book of -0.57, price-to-sales of 0.28. Over the past 52 weeks the stock has ranged between $0.08 and $3.63, and currently trades 97.8% below its 52-week high.

On profitability, Aspira Women's Health Inc. generates a return on equity (ROE) of 203.31% — well above the market average, a sign of a high-quality business, return on capital employed of -400.00%, an operating margin of -77.22%, a net profit margin of -115.13%.

Official website: aspirawh.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides